Submission guidelines

Submit manuscript

Please read the guidelines in full before submitting your manuscript.
Manuscripts not conforming to these guidelines may be returned.

Submit Manuscript   opens in a new tab

The Journal recommends that authors follow the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals formulated by the International Committee of Medical Journal Editors (ICMJE).

Sage is committed to upholding the integrity of the academic record. We encourage authors to refer to the Committee on Publication Ethics’ International Standards for Authors and view the author responsibilities section on the Sage Journal Author Gateway.

We also encourage you to familiarize yourself with our Editorial Policies and our Publication Ethics Policies.

Sage Publishing disseminates high-quality research and engaged scholarship globally, and we are committed to diversity and inclusion in publishing. We encourage submissions and peer review from a diverse range of authors and reviewers from across all countries and backgrounds. Read our diversity, equity, and inclusion pledge.

There are no fees payable to submit or publish in this journal. Open access options are available – see below.

Please read the guidelines below then submit your manuscript here.

Access: Subscription
APC: See article processing charge information below
Accepts preprints? Yes
Identity transparency: Single anonymized

There are no fees payable to submit or publish in this journal.

Figures submitted in color will be published in color in the online version of the journal at $800. If you wish to have color figures in the printed version, $200 fees apply.

Optional open access publishing is available for a fee via the Sage Choice program, and Open Access agreements, where authors can publish open access either discounted or free of charge depending on the agreement with Sage. Find out if your institution is participating by visiting Open Access Agreements at Sage. Open Access agreement eligibility is determined by the corresponding author’s affiliation matching an agreement at acceptance. For more information on Open Access publishing options at Sage please visit Sage Open Access.

For information on funding body compliance, and depositing your article in repositories, please visit Sage’s Author Archiving and Re-Use Guidelines and Publishing Policies.

Your article must be within the scope of the journal and be of sufficient quality. If not, it will not be reviewed. Please read the journal’s Aims and Scope to see if your article is appropriate.

The manuscript must be your original work, you must have the rights to the work, and you must have obtained and be able to supply all necessary permissions for the reproduction of any copyright works not owned by you, including figures, illustrations, tables, lengthy quotations, or other material previously published elsewhere.

AI-enabled technologies and precision oncology are advancing at an unprecedented pace; however, a divide currently exists between these technological strides and their pragmatic integration into clinical settings. Clinicians require evidence-based research to acquaint themselves with AI tools and understand the methodologies to incorporate them into their practice. With AI in Precision Oncology serving as a foremost resource, and with the exceptional research-based content we will provide to the community, we aspire to bridge this divide.

Authors are required to provide descriptions of an AI system’s use in their Materials and Methods section. Include the name and version of the software, the date of the original use, and all relevant prompts, queries or cues that initiated the AI’s response. Potential biases and limitations of the outcomes of AI use should be discussed by the authors when presenting their results. 

Use generic product or drug names in manuscript titles, rather than trade or trademarked names. If a trade name must be used, ensure the proper indication of trademark, copyright, or service mark. 

All file names should be in English and contain only alphanumeric characters.

Article types

Original Research 

Reports of new research on AI technology in the diagnosis, care or treatment of cancers, or that affect critical topics in the management of medical practice in oncology.

  • 4,000-word limit limit
  • Structured abstract of no more than 350 words
  • Maximum of ten (10) figures 
  • Maximum of eight (8) tables 

Review Article 

Review Articles provide a service to clinicians and researchers by summarizing the current state of a topic.  AI in Precision Oncology will consider a wide range of review articles that either report on the literature or that provide meta-analyses of research findings. We will consider both short form and long form reviews with no strict word limit, or figure, table or reference count limits.

  • Short form reviews are typically fewer than 4,000 words; have an unstructured abstract of no more than 250 words (to outline the topic, relevance and direction of the review); have a maximum of six (6) figures and/or tables; and have a maximum of forty (40) references.
     
  • Long form reviews are typically up to 10,000 words; have a structured or unstructured abstract of no more than 350 words (state the subject of the review and its importance to the field); and have a maximum of ten (10) figures and eight (8) tables.

Clinical Case Report

Report of a unique medical case and its teaching relevance

  • 1,500-word limit
  • Brief, unstructured abstract
  • Appropriate case presentation; scrupulous care should be used regarding patient data and privacy
  • Maximum of two (2) figures and tables
  • Maximum of six (6) references

Technical Case Study

Report of a distinct, practical application of AI tools in oncology

  • 1,500-word limit
  • Brief, unstructured abstract
  • Case presentation to describe tools/technologies and their use, with particular emphasis on the improvement of patient care and patient outcomes
  • Maximum of two (2) figures and tables
  • Maximum of six (6) references

Commentary 

Commentaries offer insightful perspectives, analyses, or discussions on current research, trends, emerging challenges, or even controversial topics within AI in Precision Oncology. They can serve as a platform for thought leaders to highlight specific issues, encourage debates, or provide a critical lens through which to view particular subjects. While commentaries are generally flexible in structure, they should have a clear argument or point. They might address the implications of a specific study, discuss a policy or practice issue, or tackle broader challenges in the realm of AI and oncology.

  • 1500-word limit 
  • A brief, unstructured abstract of no more than 200 words that outlines the primary focus and significance of the commentary.
  • May include up to two (2) figures OR tables. These could be graphs, charts, or illustrations that aid in conveying the author's message.
  • A maximum of ten (10) key references. Commentary pieces should contain citations that provide context and support for the claims or perspectives presented.

Letter to the Editor 

Brief comment on a topic of general interest to the AI in Precision Oncology community, on a recent article in the journal. Comments on an article will be provided to the original authors to invite their Response;  the Response will be co-published with the Letter whenever possible. Correspondence will be published at the discretion of the Editor

  • 500-word limit 
  • May include one (1) figure OR table
  • Maximum of five (5) references

Invited submission types

Response to Letter 

If you have published with AI in Precision Oncology, and a reader of the journal has written to comment, you will be invited to respond to their letter. Correspondence will be published at the discretion of the Editor

  • 500-word limit 
  • May include one (1) figure OR table
  • Maximum of five (5) references

Book Review 

We welcome proposals for reviews of recent scholarly books relevant to AI in medicine, and having relevance to Oncology care. Please contact the Editorial Office either to suggest a book, or to volunteer a review. 

Reviews will be screened to ensure they meet the goals of the journal. 

Closing Page 

Thought leaders, clinicians, innovators may be invited to provide a featured opinion or reflection for the “closing page” of an issue. If you are interested in providing an inspiring, thought-provoking discussion, please submit a description to the Editorial Office for consideration.

As only 6 such pieces are published annually, we will be very selective.

Interview

Interviews with selected authors, industry leaders, or other influential thinkers in AI in oncology will be invited by the Editor-in-Chief to discuss their work and their vision of the state of the field.

This section is not open for submission, but if you have a person whom you think can provide a unique and valuable perspective, contact the Editorial Office with your suggestion.

Prompt Assistance

This brief, practical “tip” should provide a specific use-case of a LLM or Generative AI engine as a real-time assistance to any part of your work as a medical practitioner. They should provide the text of the prompt, the software used for response generation, and commentary on the usability or usefulness of the outcome.

Submit your idea to the Editorial Office for consideration.

Feature 

Features will be invited by the Editorial Board to provide insightful, topical discussion of topics of interest to our audience.

Word limits do NOT include the abstract, disclosure statements, author contribution statements, funding information, acknowledgments, tables, figure legends, or references. 

AI in Precision Oncology welcomes format-neutral manuscripts for first-time submissions. Newly submitted manuscripts will not be un-submitted for formatting issues. However, after the initial peer review process, revised submissions must follow correct journal formatting and file guidelines, as described below in the Instructions for Authors. Please note that there are certain compulsory elements (ie: any/all necessary IRB approvals, author disclosures, author contribution statements, etc.) for all new submissions. Manuscripts submitted without this information will be un-submitted and the author will be asked to add the required components.

Clinical trial registration

The journal conforms to the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first participant enrollment as a condition of consideration for publication. The trial registry name and URL, and registration number must be included at the end of the abstract.

If your research involves animals, you will be asked to confirm that you have carefully read and adhered to the ARRIVE guidelines.

Formatting your manuscript

Accepted file types

The preferred format for your manuscript is Word. You do not need to follow a template, but please ensure your heading levels are clear, and the sections clearly defined.

The LaTeX files are also accepted. A LaTeX template is available on the Sage Journal Author Gateway.

Your article title, keywords, and abstract all contribute to its position in search engine results, directly affecting the number of people who see your work. For details of what you can do to influence this, visit How to help readers find your article online.

Title

Your manuscript’s title should be concise, descriptive, unambiguous, accurate, and reflect the precise contents of the manuscript. A descriptive title that includes the topic of the manuscript makes an article more findable in the major indexing services.

Abstract

Please include a structured abstract of 350 words for Original Research between the title and main body of your manuscript that concisely states the purpose of the research, major findings, and conclusions. If your research includes clinical trials, the trial registry name and URL, and registration number must be included at the end of the abstract. Submissions that do not meet this requirement will not be considered.

For clinical trials, the trial registry name and URL, and registration number must be included at the end of the abstract.

Keywords

Please include a minimum of 4 keywords, listed after the abstract. Keywords should be as specific as possible to the research topic.

Artwork, figures, and other graphics

For guidance on the preparation of illustrations, pictures, and graphs in electronic format, please read Sage’s artwork guidelines.

Figures supplied in color will appear in color online regardless of whether or not these illustrations are reproduced in color in the printed version. If you have requested color reproduction in the print version, we will advise you of the costs on receipt of your accepted article.

Please ensure that you have obtained any necessary permission from copyright holders for reproducing any illustrations, tables, figures, or lengthy quotations previously published elsewhere. For further information including guidance on fair dealing for criticism and review, please see the Frequently Asked Questions page on the Sage Journal Author Gateway.

Acknowledgments

If you are including an Acknowledgements section, this will be published at the end of your article. The Acknowledgments section should include all contributors who do not meet the criteria for authorship. Per ICMJE recommendations, it is best practice to obtain consent from non-author contributors who you are acknowledging in your manuscript.

Writing assistance and third party submissions: if you have received any writing or editing assistance from a third-party, for example a specialist communications company, this must be clearly stated in the Acknowledgements section and in the covering letter. Please see the Sage Author Gateway for what information to include in your Acknowledgements section. If your submission is being made on your behalf by someone who is not listed as an author, for example the third-party who provided writing/editing assistance, you must state this in the Acknowledgements and also in your covering letter. Please note that the journal editor reserves the right to not consider submissions made by a third party rather than by the author/s themselves.

Author contributions

You will be asked to list the contribution of each author as part of the submission process. Please include the Author Contributions heading within your submission after the Acknowledgements section. The information you give on submission will then show under the Author Contributions heading later at the proofing stage.

Statements and declarations

Please include a section with the heading ‘Statements and Declarations’ at the end of your submitted article, after the Acknowledgements section [and Author Contributions section if applicable] including each of the sub-headings listed below. If a declaration is not applicable to your submission, you must still include the heading and state ‘Not applicable’ underneath. Please note that you may be asked to justify why a declaration was not applicable to your submission by the Editorial Office.

Ethical considerations

Please include your ethics approval statements under this heading, even if you have already included ethics approval information in your methods section. If ethical approval was not required, you need to explicitly state this. You can find information on what to say in your ethical statements as well as example statements on our Publication ethics and research integrity policies page.

All papers reporting studies involving human participants, human data or human tissue must state that the relevant Ethics Committee or Institutional Review Board approved the study, or waived the requirement for approval, providing the full name and institution of the review committee in addition to the approval number. If applicable, please also include this information in the Methods section of your manuscript.

Please include any participant consent information under this heading and state whether informed consent to participate was written or verbal. If the requirement for informed consent to participate has been waived by the relevant Ethics Committee or Institutional Review Board (i.e. where it has been deemed that consent would be impossible or impracticable to obtain), please state this. If this is not applicable to your manuscript, please state ‘Not applicable’ in this section. More information and example statements can be found on our Publication ethics and research integrity policies page.

Submissions containing any data from an individual person (including individual details, images or videos) must include a statement confirming that informed consent for publication was provided by the participant(s) or a legally authorized representative. Non-essential identifying details should be omitted. Please do not submit the participant’s actual written informed consent with your article, as this in itself breaches the patient’s confidentiality. The Journal requests that you confirm to us, in writing, that you have obtained written informed consent to publish but the written consent itself should be held by the authors/investigators themselves, for example in a patient’s hospital record. The confirmatory letter may be uploaded with your submission as a separate file in addition to the statement confirming that consent to publish was obtained within the manuscript text. If this is not applicable to your manuscript, please state ‘Not applicable’ in this section.

Declaration of conflicting interest

The journal requires a declaration of conflicting interests from all authors so that a statement can be included in your article. For guidance on conflict of interest statements, see our policy on conflicting interest declarations and the ICMJE recommendations.

If no conflict exists, your statement should read: ‘The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article’.

Funding statement

All articles need to include a funding statement, under a separate heading, even if you did not receive funding. You’ll find guidance and examples on our Funding page.

Data availability

The Journal is committed to facilitating openness, transparency and reproducibility of research, and has the following research data sharing policy. For more information, including FAQs please visit the Sage Research Data policy pages.

Subject to appropriate ethical and legal considerations, authors are encouraged to:

  • Share your research data in a relevant public data repository
  • Include a data availability statement linking to your data. If it is not possible to share your data, use the statement to confirm why it cannot be shared.
  • Cite this data in your research

Reference style and citations

The journal follows the Sage Vancouver reference style. View the Sage Vancouver guidelines to ensure your manuscript conforms.

Every in-text citation must have a corresponding citation in the reference list and vice versa. Corresponding citations must have identical spelling and year.

Authors should update any references to preprints when a peer reviewed version is made available, to cite the published research. Citations to preprints are otherwise discouraged.

EndNote

If you use EndNote to manage references, you can download the Sage Vancouver EndNote output file

Supplemental material

This Journal can host additional materials online (e.g. datasets, podcasts, videos, images etc.) alongside the full text of the article. Your supplemental material must be one of our accepted file types. For that list and more information please refer to our guidelines on submitting supplemental files.

English language editing services

Authors seeking assistance with English language editing, translation, or figure and manuscript formatting to fit the journal’s specifications should consider using Sage Author Services. Visit Sage Author Services for further information.

As part of the submission process you will need to confirm that this is your original work, that you have the rights in the work, that this is for first publication in this Journal, that it is not being considered for/has not already been published elsewhere, and that you have obtained and can supply all necessary permissions for the reproduction of any copyright works not owned by you.

Please see our guidelines on prior publication and note that the journal may accept submissions of manuscripts that have been posted on preprint servers.

Preprints

The journal will consider submissions of manuscripts that have been posted on preprint servers.

Please enter the preprint DOI in the designated field when submitting your manuscript. We advise that you inform the Journal Editorial office about your posted preprint at submission.

Note that you should not post an updated version of your manuscript on a preprint server while it is being peer reviewed.

Learn more about our preprint policy.

Submission site

Submit your manuscript online via Sage Track.

IMPORTANT: Please check whether you already have an account in Sage Track before trying to create a new one. If you have reviewed or authored for the journal in the past year it is likely that you will have had an account created. For further guidance on submitting your manuscript online please visit ScholarOne Online Help.

Manuscripts should only be submitted with the consent of all contributing authors. The individual responsible for submitting the manuscript should carefully check that all those whose work contributed to the manuscript are listed as authors.

Ensure you upload all relevant manuscript files, including any additional supplemental files (including reporting guidelines where relevant).

Authorship

Author contributions 

As part of our commitment to ensuring an ethical, transparent and fair peer review and publication process, AIPO  has adopted CRediT (Contributor Role Taxonomy). CRediT is a high-level taxonomy, including 14 roles, which is used to describe each other's individual contribution to the work.  

You will be asked to list the contribution of each author as part of the submission process. Please include the Author Contributions heading within your submission after the Acknowledgements section. The information you give on submission will then show under the Author Contributions heading later at the proofing stage. For more informal, please see our CRediT Gateway page

Corresponding authors must specify the contributions of each co-author using the CRediT (Contributor Roles Taxonomy) framework. The roles include:  

- Conceptualization  
- Data curation  
- Formal analysis  
- Funding acquisition  
- Investigation  
- Methodology  
- Project administration  
- Resources  
- Software  
- Supervision  
- Validation  
- Visualization  
- Writing – original draft  
- Writing – review and editing  

It is important to note that not every CRediT role will be relevant to each manuscript, and individual authors may fulfill multiple roles. For further information on CRediT we encourage you to explore https://credit.niso.org

Please note that AI chatbots, for example ChatGPT, should not be listed as authors. For more information see the policy on Use of ChatGPT and generative AI tools.

Files

  • Your manuscript, properly formatted according to all stipulations above, and within the scope of the journal.
  • Figures and images.
  • Images should not reveal the name of a patient or a manufacturer.
  • In each legend, provide explanations for any abbreviations or symbols that appear in the figure.
  • Figures that will not be reproduced in color must be readable and interpretable in black and white.
  • Tables may be included after the references at the end of the main text file, or uploaded as a single, separate Word file. All tables should be editable.
  • Supplemental material. This journal can host additional materials online (e.g. datasets, podcasts, videos, images, etc) alongside the full-text of the article. Your supplemental material must be one of our accepted file types. For that list and more information please refer to our guidelines on submitting supplemental files.

Other information required for submission

  • ORCID ID of the submitting author.
    • It is strongly encouraged that all co-authors ensure their ORCID IDs are linked to their accounts in the submission system prior to article acceptance, as this is the only way to have their ORCID ID present on the published article. ORCID IDs cannot be added to manuscripts after acceptance/publication. Please note that each co-author must log in to the submission system to add their own ORCID ID to their account. To add an ORCID ID, edit your account, click the link when prompted, and sign into your ORCID account to validate your ID. You will then be redirected back to the submission system and your ORCID ID will become part of your accepted publication’s metadata.
    • Please create an ORCID ID if you do not already have one or visit our ORCID homepage to learn more.
  • Complete list of authors, with their institutional affiliations.
    • The author information you enter at submission must exactly match what is included on your manuscript and/or title page, including full names, academic affiliations, and corresponding author contact details.
    • The listed affiliation should be the institution where the research was conducted. If an author has moved to a new institution since completing the research, the new affiliation can be included in a note at the end of the manuscript.
    • All listed authors must meet the criteria for authorship (above).
    • All persons eligible for authorship must be included at the time of submission.
    • All authors must have given consent for the manuscript to be submitted in its current form.
  • Keywords: During submission, you may be asked to select or enter keywords for your manuscript. These keywords are used to match appropriate reviewers to your manuscript.
  • The number of figures, tables, and words in your manuscript.
  • Funder information: Name, grant/award number.
  • You may be required to enter your declaration of conflicting interest as part of the submission process, in addition to listing it on your manuscript and/or title page. Please have it on hand.
  • If you have posted your manuscript to a preprint server, you will be asked to supply the DOI (this does not prohibit submission, but no changes should be made to the preprint version while your manuscript is under evaluation in this journal). Please see our guidelines on prior publication. If the article is accepted for publication, the author may re-use their work according to the journal's author archiving policy. If your manuscript is accepted, you must include a link in your preprint to the final version of your published article.

The following summary describes the peer review process for this journal:
Identity transparency:Single-anonymized
Reviewer interacts with: Editor
Review information published: None

Your manuscript will undergo an initial evaluation. If it does not conform to the requirements laid out in these guidelines, it will be returned to you for amendments prior to peer review. Manuscripts may be desk rejected without peer review at this point if they are out of scope for the journal or otherwise unsuitable.

After passing the initial evaluation, your manuscript will then be peer reviewed. You can log in at any time to check the status of your manuscript. We will notify you when a decision has been reached.

After internal editorial screening for suitability, all manuscript submissions containing original research or that comprise scholarly review are subject to rigorous, independent, external peer review. Editorials, correspondence, news features, and/or Invited opinion or perspective contributions in other sections of the journal are subject to stringent editorial oversight; at need, external, independent review will be arranged to address specialized topics. Final decisions for publication are solely the responsibility of the Editor(s)-in-Chief.

To ensure the integrity of the peer review process we assign reviewers and cannot accept author recommendations.

All manuscripts are reviewed as rapidly as possible, while maintaining rigor. Reviewers make comments to the author and recommendations to the Editor who then makes the final decision on all manuscripts, including those appearing in a special issue or special collection. The Editor or members of the Editorial Board may occasionally submit their own manuscripts for possible publication in the Journal. In these cases, the peer review process will be managed by alternative members of the Board and the submitting Editor/Board member will have no involvement in the decision-making process.

As a COPE member we engage with multiple forms of post-publication discussion in line with wider guidance from Sage: Commentaries, Critiques and Responses.

You can view our complaints and appeals policy here.

Read Sage's complete peer review policy.

Editorial Board Member Disclosure
In addition to standard conflict of interest disclosures, authors who are members of the Editorial Board of AIPO must explicitly disclose this role when submitting a manuscript to the journal. Transparency regarding editorial affiliations helps maintain trust in the peer review process and supports the integrity of the scientific record.
 
Editorial Board members who submit manuscripts must include a statement confirming that they had no involvement in the peer review or editorial decision-making process for their own submission. In accordance with journal policy, no member of the Editorial Leadership of AIPO (including the Editor-in-Chief, Deputy/Associate/Guest Editors, or Editorial Board members) is permitted to participate in the review or decision process for submissions where there is a potential or actual competing interest. This includes, but is not limited to, research or review papers of their own authorship or co-authorship. In such cases, an independent member of the editorial leadership will have full discretion to manage the review and decision process.
 
This disclosure should be included as part of the standard Declaration of Conflicting Interests statement at the end of the manuscript.
 
Examples:

• Author [Full Name] is a member of the Editorial Board of AIPO and has no further conflicts to declare. The author did not take part in the peer review or decision-making process for this submission.
• Author [Full Name] is a member of the Editorial Board of AIPO. The author did not take part in the peer review or decision-making process for this submission. Additional conflicts of interest include: [brief description of other roles, relationships, or potential conflicts].

Plagiarism

The journal and Sage take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. Please read Sage's complete policy on plagiarism and the actions we may take.

Contributor’s Publishing Agreement

Before publication, we require the author as the rights holder to sign a Journal Contributor’s Publishing Agreement. Sage’s Journal Contributor’s Publishing Agreement is an exclusive license agreement which means that the author retains copyright in the work but grants Sage the sole and exclusive right and license to publish for the full legal term of copyright. Exceptions may exist where an assignment of copyright is required or preferred by a proprietor other than Sage. In this case copyright in the work will be assigned from the author to the society. For more information please visit the Sage Journal Author Gateway.

Preprints

If your manuscript was posted on a preprint server prior to acceptance, you must include a link in your preprint to the final published version of your published article.

Production

Your Sage Production Editor will keep you informed as to your article’s progress throughout the production process. Proofs will be made available to the corresponding author via our editing portal, Sage Edit, or by email, and should be returned promptly to avoid delaying publication. Authors are reminded to check their proofs carefully to confirm that all author information, including names, affiliations, sequence, and contact details are correct, and that Funding and Conflict of Interest statements, if any, are accurate. This is the final opportunity to make changes to your manuscript. Further corrections will not be possible after publication. Changes to the author list are not permitted at this stage.

Publication

OnlineFirst publication: This enables us to publish final articles online immediately, without waiting for assignment to a future issue of the Journal. This usually significantly reduces publication lead time. Visit the Sage Journals help page for more details, including how to cite OnlineFirst articles.

Access to your published article: We provide you with online access to your published article. The online access link is provided to the corresponding author for sharing with their co-authors.

Promoting your article

Publication is not the end of the process. Between us, we can ensure that your article is found, read, downloaded and cited as widely as possible. Many of the most effective tactics are those you can do quickly and easily to your network of contacts and peers. Visit the Promote Your Article page on the Sage Journal Author Gateway for numerous resources to help you promote your work.

The Sage Journal Author Gateway has some general advice on how to get published, plus links to further resources. Sage Author Services also offers authors a variety of ways to improve and enhance your article including English language editing, plagiarism detection, and video abstract and infographic preparation.

If you have any questions about publishing with Sage, please visit the Sage Journals Solutions Portal.

You can view our complaints and appeals procedure.

Contact us

You can direct any questions to the journal’s editorial office: AIPO.pra@sagepub.com.

A small number of independent proposals for Special issues may be considered. Any proposal will be reviewed by the Editorial and publishing leadership; resulting issue is subject to full review by existing Editorial Board members. We reserve the right to cease development of any special issue if problems with the submitted content or editorial practices are identified.